PRELUDE THERAPEUTICS INC's ticker is PRLD and the CUSIP is 74065P101. A total of 61 filers reported holding PRELUDE THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $15,000 | -37.5% | 5,063 | -4.1% | 0.00% | – |
| Q2 2023 | $24,000 | -20.0% | 5,279 | +0.4% | 0.00% | – |
| Q1 2023 | $30,000 | +15.4% | 5,258 | +22.3% | 0.00% | – |
| Q4 2022 | $26,000 | -7.1% | 4,299 | +2.4% | 0.00% | – |
| Q3 2022 | $28,000 | +115.4% | 4,200 | +67.9% | 0.00% | – |
| Q2 2022 | $13,000 | -40.9% | 2,501 | -21.0% | 0.00% | – |
| Q1 2022 | $22,000 | -63.9% | 3,166 | -34.5% | 0.00% | – |
| Q4 2021 | $61,000 | -60.1% | 4,832 | -1.5% | 0.00% | – |
| Q3 2021 | $153,000 | +47.1% | 4,906 | +34.2% | 0.00% | – |
| Q2 2021 | $104,000 | -30.7% | 3,656 | +6.0% | 0.00% | – |
| Q1 2021 | $150,000 | -26.1% | 3,449 | +21.8% | 0.00% | – |
| Q4 2020 | $203,000 | – | 2,831 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Orbimed Advisors | 10,909,256 | $33,709,601 | 0.72% |
| Boxer Capital, LLC | 2,495,018 | $7,709,606 | 0.41% |
| Sio Capital Management, LLC | 350,000 | $1,081,500 | 0.34% |
| Baker Brothers Advisors | 10,123,824 | $31,282,616 | 0.18% |
| EcoR1 Capital, LLC | 1,157,452 | $3,576,527 | 0.12% |
| GSA CAPITAL PARTNERS LLP | 70,583 | $218 | 0.02% |
| Pale Fire Capital SE | 30,781 | $95,113 | 0.01% |
| Woodline Partners LP | 200,000 | $618,000 | 0.01% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 143,957 | $444,827 | 0.00% |
| EXCHANGE TRADED CONCEPTS, LLC | 32,907 | $101,683 | 0.00% |